This activity is the fourth and final module in a series of four educational activities on managing side effects of newer therapies for ALL. Dr. Brandon Hayes-Lattin from Oregon Health & Sciences University, discusses strategies to prevent, monitor, and manage VOD associated with CD22-directed ADC therapy.